Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors.
Tan B, Liu C, Li K, Jadhav P, Lambrinidis G, Zhu L, Olson L, Tan H, Wen Y, Kolocouris A, Liu W, Wang J. Tan B, et al. Among authors: tan h. J Med Chem. 2023 Nov 9;66(21):14544-14563. doi: 10.1021/acs.jmedchem.3c00995. Epub 2023 Oct 19. J Med Chem. 2023. PMID: 37857371 Free PMC article.
Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
Jadhav P, Huang B, Osipiuk J, Zhang X, Tan H, Tesar C, Endres M, Jedrzejczak R, Tan B, Deng X, Joachimiak A, Cai J, Wang J. Jadhav P, et al. Among authors: tan b, tan h. Eur J Med Chem. 2024 Jan 15;264:116011. doi: 10.1016/j.ejmech.2023.116011. Epub 2023 Dec 5. Eur J Med Chem. 2024. PMID: 38065031
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.
Tan B, Zhang X, Ansari A, Jadhav P, Tan H, Li K, Chopra A, Ford A, Chi X, Ruiz FX, Arnold E, Deng X, Wang J. Tan B, et al. Among authors: tan h. bioRxiv [Preprint]. 2023 Dec 3:2023.12.01.569653. doi: 10.1101/2023.12.01.569653. bioRxiv. 2023. Update in: Science. 2024 Mar 29;383(6690):1434-1440. doi: 10.1126/science.adm9724 PMID: 38076941 Free PMC article. Updated. Preprint.
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.
Raghav KPS, Guthrie KA, Tan B Jr, Denlinger CS, Fakih M, Overman MJ, Dasari NA, Corum LR, Hicks LG, Patel MS, Esparaz BT, Kazmi SM, Alluri N, Colby S, Gholami S, Gold PJ, Chiorean EG, Kopetz S, Hochster HS, Philip PA. Raghav KPS, et al. Among authors: tan b jr. J Clin Oncol. 2025 Jan 6:JCO2401710. doi: 10.1200/JCO-24-01710. Online ahead of print. J Clin Oncol. 2025. PMID: 39761503
5,758 results